02 February, 2023 in Blog / 0 Comments 02 Feb 2023 NexPlasmaGen to present to the OBIO Investment Summit
23 June, 2022 in Blog / 0 Comments NexPlasmaGen to present at the MedInvest Oncology Investor Conference
03 November, 2021 in Blog / 0 Comments NexPlasmaGen’s CPJ breast cancer in vivo preclinical trials completed